The information that ACE inhibitors and AT1R blockers may increase the risk of SARS-CoV-2 infection and adversely affect the course of COVID-19 was disseminated quite quickly by global social media and caused some confusion in the medical community. Here, AGTR1 is linked to COVID-19.